Advances in Oral Coagulants

This article reviews current and future treatment practices concerning oral anticoagulants. In the second decade of the 21st millennium clinicians can finally treat thrombotic disease with long-awaited new oral anticoagulant medications. In addition, improvements have been made in managing warfarin,...

Descripción completa

Detalles Bibliográficos
Autor principal: Pollak, Eleanor S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Communications and Publications Division (CPD) of the IFCC 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975311/
https://www.ncbi.nlm.nih.gov/pubmed/27683431
_version_ 1782446702763966464
author Pollak, Eleanor S.
author_facet Pollak, Eleanor S.
author_sort Pollak, Eleanor S.
collection PubMed
description This article reviews current and future treatment practices concerning oral anticoagulants. In the second decade of the 21st millennium clinicians can finally treat thrombotic disease with long-awaited new oral anticoagulant medications. In addition, improvements have been made in managing warfarin, the traditional but far from obsolete medication. The first part of this review will cover current advances with warfarin treatment. The second portion will discuss specific active coagulation factor inhibitors, the new oral anticoagulants.
format Online
Article
Text
id pubmed-4975311
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Communications and Publications Division (CPD) of the IFCC
record_format MEDLINE/PubMed
spelling pubmed-49753112016-09-28 Advances in Oral Coagulants Pollak, Eleanor S. EJIFCC Research Article This article reviews current and future treatment practices concerning oral anticoagulants. In the second decade of the 21st millennium clinicians can finally treat thrombotic disease with long-awaited new oral anticoagulant medications. In addition, improvements have been made in managing warfarin, the traditional but far from obsolete medication. The first part of this review will cover current advances with warfarin treatment. The second portion will discuss specific active coagulation factor inhibitors, the new oral anticoagulants. The Communications and Publications Division (CPD) of the IFCC 2013-01-16 /pmc/articles/PMC4975311/ /pubmed/27683431 Text en Copyright © 2012 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pollak, Eleanor S.
Advances in Oral Coagulants
title Advances in Oral Coagulants
title_full Advances in Oral Coagulants
title_fullStr Advances in Oral Coagulants
title_full_unstemmed Advances in Oral Coagulants
title_short Advances in Oral Coagulants
title_sort advances in oral coagulants
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975311/
https://www.ncbi.nlm.nih.gov/pubmed/27683431
work_keys_str_mv AT pollakeleanors advancesinoralcoagulants

Ejemplares similares